NEWS
View news from our Featured Companies.
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
WINTER SPRINGS, Fla., April 05, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market opens on Friday, April 29th. IRADIMED management will host a conference call the same...
INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference
SARASOTA, Fla., April 4, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables,...
ARIANNE PHOSPHATE ISSUES SHARES AS INTEREST PAYMENT
-issuance of shares is in lieu of a cash payment DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, April 1, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate...
S&W Seed Company to Participate in the Lytham Partners Spring 2022 Investor Conference
LONGMONT, Colo., March 31, 2022 -- S&W Seed Company (Nasdaq: SANW) announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company's webcast fireside chat will be available...
SenesTech, Inc. to Participate in the Lytham Partners Spring 2022 Investor Conference
PHOENIX, March 31, 2022 -- SenesTech, Inc. (NASDAQ: SNES) announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company's webcast presentation will be available for viewing...
INVO Bioscience Reports 2021 Financial Results
Company to Host Conference Call Today at 4:30pm ET; Slide Presentation Also Available SARASOTA, Fla., March 31, 2022 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...
ARIANNE PHOSPHATE REPORTS FINANCIAL RESULTS FOR Q4 AND YE 2021
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, March 30, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Scientific Industries to Participate in the Lytham Partners Spring 2022 Investor Conference
Presentation will be at 11:00 a.m. ET on Monday, April 4, 2022BOHEMIA, NY / March 30, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it will be...
SenesTech Announces Year-End 2021 Financial and Operational Results
Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX, March 29, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors...
Zoomd Announces the Acquisition of Artificial Intelligence Marketing Platform “Albert”
Zoomd acquires substantially all of Albert's assets in a cash & stock transactionThe acquisition adds several Fortune 500 companies to Zoomd's client baseAlbert's strong focus on Google and Facebook auto-scaling is a powerful addition to the Zoomd...
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., March 24, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide...
INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting
SARASOTA, Fla., March 24, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available, is exhibiting the INVOcell solution at the 2022 Pacific Coast Reproductive Society (PCRS)...
LiqTech International Announces Financial Results for the Fourth Quarter and Full Year of 2021
BALLERUP, Denmark, March 24, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the fourth quarter and fiscal...
Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
CUPERTINO, Calif., March 24, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
SenesTech to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Tuesday, March 29, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 23, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2021, ended December 31, 2021, after the...
Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for Cotempla XR-ODT®
ENGLEWOOD, CO / March 23, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that its newly issued US patent No. 11,166,947 for Cotempla XR-ODT® (methylphenidate)...
Mogo Reports Record Revenue for Q4 2021
Record Q4 revenue of $17.0 million, up 70% year over year Subscription and services revenue growth accelerates to 135% year over year $193 million of cash and total investments at year end1 Company announces share repurchase program up to US$10 million Mogo reports in...
Mogo Announces Formation of Mogo Ventures to Manage its $124 Million Investment Portfolio
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced the formation of Mogo Ventures to manage its existing investments in strategic partners and companies...
INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
SARASOTA, Fla., March 22, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the IVC procedure it enables, announced today that Inger...
SenesTech, Inc., Announces EPA Approval and Launch of the Elevate Bait System™ with ContraPest®
The Elevate Bait System with ContraPest is specifically designed to address rat problems in above-ground locations. PHOENIX, March 22, 2022 -- SenesTech, Inc., (SNES) announced today the EPA approval of and launch of its newest product design and application, the...
Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
ENGLEWOOD, CO / March 22, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that management will participate in a panel discussion titled, "Managing Clinical Trials for...
Reviva Pharmaceuticals Holdings, Inc. to Participate at the Maxim Virtual Growth Conference
CUPERTINO, Calif., March 22, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
LiqTech International to Discuss Fourth Quarter and Fiscal Year 2021 Results on Thursday, March 24, 2022
Management to Host Conference Call on Thursday, March 24, 2022, at 9:00 a.m. ET BALLERUP, Denmark, March 21, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and...
Kiora Pharmaceuticals to Participate in Maxim Group’s 2022 Virtual Growth Conference March 28th – 30th
- To Participate in Ophthalmology Roundtable March 28, 10:00-11:00 AM ET -- To Provide On-Demand Corporate Presentation -Salt Lake City, Utah--(March 21, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") has been invited to present at...
LiqTech CEO Takes Medical Leave of Absence
BALLERUP, Denmark, March 18, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announces that Sune Mathiesen, Chief Executive Officer, has taken a...